
    
      The primary objective of this study is to evaluate the effectiveness of A-101 compared to
      Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week.

      The secondary objectives of this study are to evaluate the clinical effect of A-101 when
      applied to all treated Warts (Target Warts plus Non-Target Warts) twice a week, duration of
      response in all treated Warts (Target Warts plus Non-Target Warts), and safety of A-101.
    
  